HOKUTO

ホクトレジデント

Headquarters
Nagano
Employees
1001–5000
Business Model
B2B
Website
hokto.jp
Last Round
Convertible NoteApr 2024
Rounds
1

About

Hokuto Corporation is Japan's largest mushroom producer, specializing in the research, development, cultivation, and sale of specialty mushroom varieties including Bunashimeji (beech mushroom), Maitake, Eryngii (king oyster mushroom), and other functional fungi. The company's Mushroom General Research Institute has developed numerous hit varieties and cultivars over decades of agricultural biotechnology work. Hokuto's products are distributed across Japan and internationally through subsidiaries including Hokto Malaysia and operations in North America. Headquartered in Nagano Prefecture, Hokuto operates as a publicly listed agri-biotech company (TSE: 1379) with the largest market share in Japan's commercial mushroom cultivation industry.

Summary

HOKUTO is a Biotech company based in Nagano, Japan. Its most recent funding was a Convertible Note round in Apr 2024. Investors include ADvantage.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

ConvertibleConvertible NoteApr 2024

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HOKUTO on Indexed.vc
<a href="https://indexed.vc/companies/hokuto"><img src="https://indexed.vc/api/badge/company/hokuto" alt="HOKUTO on Indexed.vc" width="260" height="76" /></a>